ProCE Banner Activity

Long-Acting Antiretroviral Therapy at CROI 2023: Here to Stay and, Perhaps, Just Beginning

Clinical Thought

Here is my take on important studies on LA ART presented at CROI 2023, with possible future implications for your practice.

Released: March 07, 2023

Begin Activity



Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina


Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc.

ViiV Healthcare


Joseph J. Eron, Jr., MD: consultant/advisor/speaker: Gilead Sciences, Merck, ViiV; researcher: Gilead Sciences, ViiV.